Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib
The inhibition of cyclooxygenase enzymes plays an important role in the treatment of inflammatory diseases. N-Hydroxy-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide ( 3)—a primary metabolite of the highly selective COX-2 inhibitor valdecoxib—was synthesized and stabilized as its monohydrate (...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 16; no. 9; pp. 5322 - 5330 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
01.05.2008
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The inhibition of cyclooxygenase enzymes plays an important role in the treatment of inflammatory diseases.
N-Hydroxy-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide (
3)—a primary metabolite of the highly selective COX-2 inhibitor valdecoxib—was synthesized and stabilized as its monohydrate (
3a·H
2O). The anti-inflammatory properties of
3a·H
2O were investigated in carrageenan-induced edema and in acute and chronic pain models. Based on our biological investigation, we conclude that
N-hydroxy-valdecoxib
3a is an active metabolite of valdecoxib. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2008.02.088 |